GANNEX
Gannex is dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical-stage drug candidates against three different targets — FASN, THR-β, and FXR — and three combination therapies. Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma.
GANNEX
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.gannexpharma.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Current Employees Featured
Jinzi Wu Founder, Chief Executive Officer @ Gannex
Founder, Chief Executive Officer
Founder
Official Site Inspections
http://www.gannexpharma.com
- Host name: 47.75.123.183
- IP address: 47.75.123.183
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "Gannex"
Gannex - Crunchbase Company Profile & Funding
Sub-Organization of . Ascletis . Founded Date 2019; Founders Jinzi Wu; ... Contact Email pr@gannexpharma.com; Gannex is dedicated to the R&D and …See details»
Gannex Corporate Presentation E 20231205v1 - gannexpharma.com
Nov 19, 2021 $ edvholqh vljqdwxuh ri phwderolwhv lqyroylqj wkh jxw olyhu d[lv suhglfwv 05, 3')) uhvsrqvh wr )$61 lqklelwru 79% uhvxowviurp wkh )$6&,1$7(See details»
Partnership - Gannex Pharma
If you would like to know more information on partnering with Gannex, please contact our business development team through bd@gannexpharma.com. Sagimet is a clinical-stage …See details»
Gannex Pharma - Overview, News & Similar companies
Jun 11, 2024 Who is Gannex Pharma. Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma Inc. (1672.HK), is dedicated to the R&D and commercialization of new drugs …See details»
Corporate Presentation - Gannex Pharma
Jan 28, 2022 7 ASC40: First-in-Class Oral Fatty Acid Synthase (FASN) Inhibitor Reduces steatosis by blocking DNL Reduces inflammation by decreasing cytokine secretion and Th17 …See details»
Gannex Pharma Co., Ltd. | Expanded Access Navigator
To learn more about available clinical trials by Gannex, please visit www.gannexpharma.com, or visit https://clinicaltrials.gov and search by company, disease or medicine. If you have …See details»
Gannex Pharma Co Ltd.
Mar 7, 2025 ASC42 is a non-steroidal farnesoid X receptor agonist currently in clin. development for chronic liver diseases, such as nonalcoholic fatty liver disease/nonalcoholic steatohepatitis …See details»
Gannex Pharma - VentureRadar
Website: https://www.gannexpharma.com/ Gannex, a wholly-owned company of Ascletis, is dedicated to the R&D and commercialization of new drugs in the field of NASH.See details»
Gannex Pharma Co Ltd. - Drug pipelines, Patents, Clinical trials
May 2, 2023 Explore Gannex Pharma Co Ltd. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 15 news, Disease Domain:Neoplasms, Endocrinology and ...See details»
Gannex Pharma - Overview - aiHit
Gannex Pharma is a biotech company developing NASH drugs. Contact us to enroll in a NASH clinical trial... Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma Inc. …See details»
Gannex, LLC Company Profile | Raleigh, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Gannex, LLC of Raleigh, NC. Get the latest business insights from Dun & Bradstreet.See details»
Gannex Pharma Co Ltd. - Massachusetts Institute of Technology
Mar 12, 2023 Discovery Company profile page for Gannex Pharma Co Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Gannex Pharma Co., Ltd. | Reagan-Udall Foundation
To learn more about available clinical trials by Gannex, please visit www.gannexpharma.com, or visit https://clinicaltrials.gov and search by company, disease or medicine. If you have …See details»
Gannex Pharma Co Ltd. (甘莱制药有限公司) - 药物管线_专利_临床 …
关于甘莱 甘莱成立于2019年，是歌礼制药有限公司的全资子公司，致力于NASH领域新药的研发和商业化。甘莱有三种针对三种不同靶点（FASN、THRβ和FXR）的临床阶段候选药物，以及 …See details»
Gannex Pharma Co Ltd. - discovery.patsnap.com
Dec 5, 2022 Gannex is a company that provides Drug candidate, Combination therapy and more. Gannex is headquartered in United States North America. Gannex was founded in …See details»
Gannex Pharma - Products, Competitors, Financials, Employees ...
Oct 10, 2024 CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to …See details»
2024_Gannex Pharma
Jan 23, 2024 Gannex Announces Poster Presentation Describing Positive Interim 12-Week Results from Ongoing 52-Week Phase II Clinical Trial of Once-Daily ASC41 in Patients with …See details»
| Expanded Access Navigator - Reagan-Udall
The Reagan-Udall Foundation for the FDA is an independent 501(c)(3) not-for-profit organization created by Congress for the purpose of advancing regulatory science ... To learn more about …See details»
Gannex Pharma Announces New Dual Targeting Drug for NASH
Jan 5, 2022 NASH- nonalcoholic steatohepatitis, an aggressive version of the fatty liver disease, is a disorder characterized by fat build-up and inflammation in the liver. It is usually non …See details»
2023_Gannex Pharma
Feb 1, 2023 Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D 06/11/2023; Gannex Announces the Completion of Patient …See details»